AGEN-1721

N/A

Report date: 2024/12/06 14:39:40

First In Class

Base Information

Drug NameAGEN-1721

Drug Alias NameAGEN-1721AGEN1721

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Prolyl endopeptidase FAPAnti-TGF-β

TargetsProlyl endopeptidase FAPTransforming growth factor beta

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAgenus Inc

China Registration ClassN/A

Develop Information

Active CompaniesAgenus Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A